Author
Listed:
- Yinbo Zhong
(Second Affiliated Hospital of Zhejiang University School of Medicine)
- Younian Xu
(Huazhong University of Science and Technology)
- Qian Lei
(University of Electronic Science and Technology of China)
- Mengchang Yang
(The Third People’s Hospital of Chengdu)
- Saiying Wang
(The Third Xiangya Hospital of Central South University)
- Xiaoling Hu
(The First Affiliated Hospital of University of South China)
- Haihui Xie
(Dongguan People’s Hospital (The Tenth Affiliated Hospital of Southern Medical University))
- Yalan Li
(The First Clinical Medical College of Jinan University))
- Zhong Qin
(Wuxi People’s Hospital)
- Zhengfeng Gu
(Wuxi People’s Hospital)
- Jiaqiang Zhang
(Henan Provincial People’s Hospital)
- Yuexin Wang
(Cangzhou People’s Hospital)
- Jinglei Wu
(Liuzhou People’s Hospital Affiliated to Guangxi Medical University)
- Haiying Wang
(Second Affiliated Hospital of Zhejiang University School of Medicine)
- Yue Ming
(Second Affiliated Hospital of Zhejiang University School of Medicine)
- Zhongyuan Xia
(Renmin Hospital of Wuhan University)
- Haoyu Zhai
(The First People’s Hospital of Guangyuan)
- Ke Jiang
(The Affiliated Hospital of Guizhou Medical University)
- Peng Zhang
(Yibin Second People’s Hospital)
- Zhiping Wang
(Affiliated Hospital of Xuzhou Medical University)
- Liangrong Wang
(The First Affiliated Hospital of Wenzhou Medical University)
- Lin Li
(General Hospital of the Northern Theater Command of Chinese PLA)
- Zhigang Cheng
(Xiangya Hospital Central South University)
- Huayong Jiang
(Shaoxing People’s Hospital)
- Guonian Wang
(The Fourth Hospital of Harbin Medical University)
- Jingli Chen
(Huazhong University of Science and Technology)
- Zhibin Zhao
(The First People’s Hospital of Lianyungang)
- Xiangdong Chen
(Huazhong University of Science and Technology)
- Min Yan
(Second Affiliated Hospital of Zhejiang University School of Medicine)
Abstract
HSK21542, a peripherally restricted kappa opioid receptor agonist, was evaluated for efficacy and safety in patients with postoperative pain following abdominal surgery. This was assessed in two phase 3, multicentre, randomized, double-blind, controlled trials (HSK21542-301 [ClinicalTrials.gov identifier, NCT04738357] and HSK21542-303 [ClinicalTrials.gov identifier, NCT05390905]) in China. HSK21542-301 was a dual-arm study comparing HSK21542 1.0 μg/kg with placebo, while HSK21542-303 involved three arms comparing HSK21542 1.0 μg/kg with tramadol 50 mg/dose and placebo. All treatments were administered intravenously. The primary endpoint was the time-weighted summed pain intensity differences over 24 h (SPID0-24 h). Both HSK21542-301 (least squares [LS] mean [± standard error], −39.1 [1.88] vs −27.4 [1.89]; P
Suggested Citation
Yinbo Zhong & Younian Xu & Qian Lei & Mengchang Yang & Saiying Wang & Xiaoling Hu & Haihui Xie & Yalan Li & Zhong Qin & Zhengfeng Gu & Jiaqiang Zhang & Yuexin Wang & Jinglei Wu & Haiying Wang & Yue Mi, 2025.
"HSK21542 in patients with postoperative pain: two phase 3, multicentre, double-blind, randomized, controlled trials,"
Nature Communications, Nature, vol. 16(1), pages 1-13, December.
Handle:
RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-60013-y
DOI: 10.1038/s41467-025-60013-y
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-60013-y. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.